Integra Essentia Ltd: Intrinsic Value & Share Price Analysis

Last Updated: January 3, 2026, 11:36 am

All Competitor Stocks of Integra Essentia Ltd

Last Updated: January 1, 2026, 6:46 am

Below is a detailed analysis of the quarterly data for Integra Essentia Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 120.67 Cr.. The value appears strong and on an upward trend. It has increased from 78.73 Cr. (Jun 2025) to 120.67 Cr., marking an increase of 41.94 Cr..
• For Expenses, as of Sep 2025, the value is 118.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.71 Cr. (Jun 2025) to 118.29 Cr., marking an increase of 40.58 Cr..
• For Operating Profit, as of Sep 2025, the value is 2.38 Cr.. The value appears strong and on an upward trend. It has increased from 1.02 Cr. (Jun 2025) to 2.38 Cr., marking an increase of 1.36 Cr..
• For OPM %, as of Sep 2025, the value is 1.97%. The value appears strong and on an upward trend. It has increased from 1.30% (Jun 2025) to 1.97%, marking an increase of 0.67%.
• For Other Income, as of Sep 2025, the value is 0.89 Cr.. The value appears to be declining and may need further review. It has decreased from 1.15 Cr. (Jun 2025) to 0.89 Cr., marking a decrease of 0.26 Cr..
• For Interest, as of Sep 2025, the value is 0.76 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.62 Cr. (Jun 2025) to 0.76 Cr., marking an increase of 0.14 Cr..
• For Depreciation, as of Sep 2025, the value is 0.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.91 Cr. (Jun 2025) to 0.92 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Sep 2025, the value is 1.59 Cr.. The value appears strong and on an upward trend. It has increased from 0.64 Cr. (Jun 2025) to 1.59 Cr., marking an increase of 0.95 Cr..
• For Tax %, as of Sep 2025, the value is 32.08%. The value appears to be increasing, which may not be favorable. It has increased from 15.62% (Jun 2025) to 32.08%, marking an increase of 16.46%.
• For Net Profit, as of Sep 2025, the value is 1.07 Cr.. The value appears strong and on an upward trend. It has increased from 0.54 Cr. (Jun 2025) to 1.07 Cr., marking an increase of 0.53 Cr..
• For EPS in Rs, as of Sep 2025, the value is 0.01. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 5:10 am

Last Updated: September 5, 2025, 7:45 am

Last Updated: December 4, 2025, 1:27 am

Below is a detailed analysis of the balance sheet data for Integra Essentia Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 107.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 107.00 Cr..
• For Reserves, as of Sep 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Sep 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 26.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 14.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 46.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 257.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 221.00 Cr. (Mar 2025) to 257.00 Cr., marking an increase of 36.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
• For Other Assets, as of Sep 2025, the value is 177.00 Cr.. The value appears strong and on an upward trend. It has increased from 139.00 Cr. (Mar 2025) to 177.00 Cr., marking an increase of 38.00 Cr..
• For Total Assets, as of Sep 2025, the value is 257.00 Cr.. The value appears strong and on an upward trend. It has increased from 221.00 Cr. (Mar 2025) to 257.00 Cr., marking an increase of 36.00 Cr..

Notably, the Reserves (65.00 Cr.) exceed the Borrowings (40.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Integra Essentia Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.28 (Mar 24) to 0.04, marking a decrease of 0.24.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.28 (Mar 24) to 0.04, marking a decrease of 0.24.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to 0.07, marking a decrease of 0.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.59. It has increased from 1.28 (Mar 24) to 1.59, marking an increase of 0.31.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.59. It has increased from 1.28 (Mar 24) to 1.59, marking an increase of 0.31.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4.14. It has increased from 3.03 (Mar 24) to 4.14, marking an increase of 1.11.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 2. It has decreased from 0.25 (Mar 24) to 0.10, marking a decrease of 0.15.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.07. This value is within the healthy range. It has decreased from 0.21 (Mar 24) to 0.07, marking a decrease of 0.14.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.20 (Mar 24) to 0.05, marking a decrease of 0.15.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 0.16 (Mar 24) to 0.03, marking a decrease of 0.13.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 0.16 (Mar 24) to 0.03, marking a decrease of 0.13.
• For PBDIT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has decreased from 8.38 (Mar 24) to 2.64, marking a decrease of 5.74.
• For PBIT Margin (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. It has decreased from 7.04 (Mar 24) to 1.76, marking a decrease of 5.28.
• For PBT Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 10. It has decreased from 6.84 (Mar 24) to 1.42, marking a decrease of 5.42.
• For Net Profit Margin (%), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 5. It has decreased from 5.51 (Mar 24) to 0.88, marking a decrease of 4.63.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 8. It has decreased from 5.56 (Mar 24) to 0.86, marking a decrease of 4.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 15. It has decreased from 13.17 (Mar 24) to 2.26, marking a decrease of 10.91.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 10. It has decreased from 15.66 (Mar 24) to 4.46, marking a decrease of 11.20.
• For Return On Assets (%), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 5. It has decreased from 7.65 (Mar 24) to 1.73, marking a decrease of 5.92.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.02, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.15, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.09. It has increased from 1.53 (Mar 24) to 2.09, marking an increase of 0.56.
• For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has increased from 0.76 (Mar 24) to 2.27, marking an increase of 1.51.
• For Quick Ratio (X), as of Mar 25, the value is 2.27. This value exceeds the healthy maximum of 2. It has increased from 0.76 (Mar 24) to 2.27, marking an increase of 1.51.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.64. This value is within the healthy range. It has decreased from 41.29 (Mar 24) to 7.64, marking a decrease of 33.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.55. This value is within the healthy range. It has decreased from 28.17 (Mar 24) to 3.55, marking a decrease of 24.62.
• For Enterprise Value (Cr.), as of Mar 25, the value is 251.58. It has decreased from 309.80 (Mar 24) to 251.58, marking a decrease of 58.22.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.56, marking a decrease of 0.56.
• For EV / EBITDA (X), as of Mar 25, the value is 21.57. This value exceeds the healthy maximum of 15. It has increased from 13.33 (Mar 24) to 21.57, marking an increase of 8.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 24) to 0.51, marking a decrease of 0.59.
• For Price / BV (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.33, marking a decrease of 1.27.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 24) to 0.51, marking a decrease of 0.59.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis